知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

16 条记录 (耗时 0.013 秒)

    LONGITUDINAL DATA QUALITY ASSURANCE SYSTEM
    1.
    发明申请
    LONGITUDINAL DATA QUALITY ASSURANCE SYSTEM 审中-公开

    公开(公告)号：US20200160946A1

    公开(公告)日：2020-05-21

    申请号：US16356002

    申请日：2019-03-18

    申请人： Enlitic, Inc.

    发明人： Eric C. Poblenz ,  Li Yao ,  Keith Lui ,  Kevin Lyman

    IPC分类号： G16H10/60 ,  G16H15/00 ,  G16H30/40 ,  H04L29/06

    摘要： A longitudinal data quality assurance system is operable to receive a set of medical scans corresponding to a same first patient. A first chronologically ordered list of the set of medical scans is generated based on a corresponding first set of dates, where each of the corresponding first set of dates are extracted from a headers of the set of medical scans. Quality assurance data is generated for the first chronologically ordered list by performing at least one quality assurance function on at least one of the set of medical scans. A second chronologically ordered list that includes a first subset of the first set of medical scans is generated to rectify at least one continuity error of the first chronologically ordered list, indicated in the quality assurance data. The second chronologically ordered list is transmitted to a client device for display via a display device.

    CLINICAL TRIAL RE-EVALUATION SYSTEM
    6.
    发明申请
    CLINICAL TRIAL RE-EVALUATION SYSTEM 审中-公开

    公开(公告)号：US20200160964A1

    公开(公告)日：2020-05-21

    申请号：US16353952

    申请日：2019-03-14

    申请人： Enlitic, Inc.

    发明人： Kevin Lyman ,  Keith Lui ,  Anthony Upton ,  Li Yao ,  Ben Covington

    IPC分类号： G16H30/20 ,  G06T7/00 ,  G16H50/20 ,  G16H50/70 ,  G16H10/60 ,  G06F21/62 ,  G16H50/30

    摘要： A clinical trial re-evaluation system is operable to perform at least one assessment function on a set of medical scans for each of a first subset of a set of patients of a failed clinical trial to generate automated assessment data for each of the first subset of the set of patients. The first subset of the set of patients corresponds to a subset of human assessment data determined to have failed to meet criteria of the clinical trial. Patient re-evaluation data is generated for each of the first subset of the set of patients by comparing the automated assessment data to the criteria. The patient re-evaluation data for a second subset of the first subset of the set of patients indicates the automated assessment data passes the criteria. Trial re-evaluation data is generated based on the patient re-evaluation data for transmission to a computing device for display.

    LESION TRACKING SYSTEM
    7.
    发明申请
    LESION TRACKING SYSTEM 审中-公开

    公开(公告)号：US20200160945A1

    公开(公告)日：2020-05-21

    申请号：US16353935

    申请日：2019-03-14

    申请人： Enlitic, Inc.

    发明人： Kevin Lyman ,  Anthony Upton ,  Ben Covington ,  Li Yao ,  Keith Lui

    IPC分类号： G16H10/60 ,  G16H30/20 ,  G06T7/00 ,  G16H50/20 ,  G16H50/70 ,  G06F21/62 ,  G16H50/30

    摘要： A lesion tracking system is operable to receive a first medical scan and second medical scan associated with a patient ID. A lesion area calculation is performed on a first subset of image slices determined to include a lesion detected in the first medical to generate a first set of lesion area measurements. The lesion area calculation is performed on a second subset of image slices determined to include the lesion in the second medical scan to generate a second set of lesion area measurements. A lesion volume calculation is performed on the first set of lesion area measurements and the second set of lesion area measurements to generate a first lesion volume measurement and a second lesion volume measurement, respectively, and the first and second lesion volume measurements are utilized to calculate a lesion volume change for transmission to a client device for display via a display device.